Candesartan vs Propranolol for Migraine Prevention: A Double Blind, Placebo Controlled, Double Dummy, Triple Cross-Over Study
Phase of Trial: Phase II/III
Latest Information Update: 23 Dec 2013
At a glance
- Drugs Candesartan cilexetil (Primary) ; Propranolol
- Indications Migraine
- Focus Therapeutic Use
- 27 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2013 Primary endpoint 'Days-with-headache' has been met according to results presented at the 2013 International Headache Congress.
- 30 Jun 2013 Results presented at the 2013 International Headache Congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History